Trial Information
Inclusion Criteria:
- Histologic or cytologic diagnosis of non-small cell lung carcinoma
- Progressed while on or after treatment on platinum-based regimen
- Patients may not have had more than one prior cytotoxic chemotherapy regimen
- Stage IV or IIIB
- Age at least 18 years
- Adequate liver and kidney function
- Adequate bone marrow function
Exclusion Criteria:
- Pregnancy or lactation
- Unstable medical conditions
- Chemotherapy, hormonal therapy, radiotherapy, radiopharmaceuticals or immunotherapy
within 3 weeks of TLK286
- CNS metastasis unless controlled by treatment
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Authority:
United States: Food and Drug Administration
Study ID:
TLK286.2014
NCT ID:
NCT00040638
Start Date:
July 2002
Completion Date:
August 2003
Related Keywords:
- Carcinoma, Non-Small-Cell Lung
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
Name | Location |
Arizona Cancer Center |
Tucson, Arizona 85724 |
UCLA Medical Center |
Los Angeles, California 90095-7059 |
M.D. Anderson Cancer Center |
Houston, Texas 77030 |